Implementing an OE Strategy on Plant Level

Jürgen Werani (), Volker Pfahlert (), Kai Reimers () and Gert Diederich ()
Additional contact information
Jürgen Werani: Schuh & Co. Complexity Management AG
Volker Pfahlert: Schuh & Co. Complexity Management AG
Kai Reimers: Hameln Group GmbH
Gert Diederich: Hameln Group GmbH

Chapter Chapter 13 in Leading Pharmaceutical Operational Excellence, 2013, pp 189-207 from Springer

Abstract: Abstract Hameln Pharma is a well-established contract manufacturer for sterile drug products. The aim was to develop Hameln Pharma into a modern, market-oriented, flexible and high-performing company which intends to be the first choice for its customers in the market for filling sterile liquids and related services. Hameln Pharma’s mission is to be a strategic business partner for its customers, to supply them in a fast, safe and flexible way and offer them FDA-level quality products at fair market prices. The company maintains its competitive edge by

Keywords: Operational Excellence; Business Unit; Corporate Culture; Master Plan; Core Process (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-35161-7_13

Ordering information: This item can be ordered from
http://www.springer.com/9783642351617

DOI: 10.1007/978-3-642-35161-7_13

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().